Replies to post #189823 on NorthWest Biotherapeutics Inc (NWBO)

[Ultraz2]

They are my top pick for buyout...

[JTORENCE]

monarch6500 and your point is by posting this link??

[flipper44]

Very Interesting.

General corporate purposes may include, among other things.... the financing of possible acquisitions.... -- BMY, September 12, 2018

[marzan]

No wonder the Combo trial kept pushed farther and farther out. Lp must have been bargaining a better deal than just the combo trial, imo.

[XenaLives]

Very, Very interesting....

Trace the replied thread back.

Bristol-Myers Squibb Co (NYSE:BMY) Stake Increased by BlackRock Inc.
Posted by Mary Kom on Sep 15th, 2018 Tweet
inShare

Bristol-Myers Squibb logoBlackRock Inc. increased its holdings in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 7.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,913,559 shares of the biopharmaceutical company’s stock after acquiring an additional 7,517,623 shares during the period. BlackRock Inc. owned approximately 6.85% of Bristol-Myers Squibb worth $6,193,296,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its holdings in Bristol-Myers Squibb by 7.5% during the first quarter. Massachusetts Financial Services Co. MA now owns 6,678,633 shares of the biopharmaceutical company’s stock valued at $422,423,000 after buying an additional 468,740 shares during the last quarter. Schwab Charles Investment Management Inc. increased its holdings in Bristol-Myers Squibb by 2.8% during the second quarter. Schwab Charles Investment Management Inc. now owns 6,283,205 shares of the biopharmaceutical company’s stock valued at $347,713,000 after buying an additional 172,417 shares during the last quarter. Swiss National Bank increased its holdings in Bristol-Myers Squibb by 2.7% during the second quarter. Swiss National Bank now owns 5,491,170 shares of the biopharmaceutical company’s stock valued at $303,881,000 after buying an additional 146,500 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in Bristol-Myers Squibb by 6.7% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 5,130,236 shares of the biopharmaceutical company’s stock valued at $283,907,000 after buying an additional 320,015 shares during the last quarter. Finally, Parnassus Investments CA increased its holdings in Bristol-Myers Squibb by 2.9% during the second quarter. Parnassus Investments CA now owns 3,600,000 shares of the biopharmaceutical company’s stock valued at $199,224,000 after buying an additional 100,000 shares during the last quarter. Hedge funds and other institutional investors own 72.29% of the company’s stock.

https://www.fairfieldcurrent.com/2018/09/15/bristol-myers-squibb-co-bmy-stake-raised-by-blackrock-inc.html